BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23551961)

  • 21. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
    Greinacher A; Warkentin TE
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies.
    Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Dhakal B; Pierce B; Aster RH; Padmanabhan A
    Chest; 2017 Oct; 152(4):e77-e80. PubMed ID: 28991552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, blinded study of a PF4-dependent assay for HIT diagnosis.
    Samuelson Bannow B; Warad DM; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Sharma R; Grill DE; Redman MW; Khalighi PR; Leger RR; Pruthi RK; Chen D; Sabath DE; Aster RH; Garcia DA; Padmanabhan A
    Blood; 2021 Feb; 137(8):1082-1089. PubMed ID: 32898858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia.
    Althaus K; Pelzl L; Hidiatov O; Amiral J; Marini I; Bakchoul T
    Thromb Res; 2019 Aug; 180():55-61. PubMed ID: 31220752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative interpretation of PF4/heparin-EIA optical densities in predicting platelet-activating VITT antibodies.
    Schönborn L; Thiele T; Esefeld M; El Debuch K; Wesche J; Seck SE; Kaderali L; Wolff M; Warkentin TE; Greinacher A
    J Thromb Haemost; 2022 Nov; 20(11):2579-2586. PubMed ID: 36006172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
    Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
    J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies.
    Kanack AJ; Jones CG; Singh B; Leger RR; Splinter NP; Heikal NM; Pruthi RK; Chen D; George G; Abou-Ismail MY; Wool GD; Gundabolu K; Padmanabhan A
    Blood; 2022 Dec; 140(25):2722-2729. PubMed ID: 35998675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review.
    Warkentin TE; Greinacher A
    Semin Thromb Hemost; 2023 Sep; 49(6):621-633. PubMed ID: 36455619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
    Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
    Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.
    Raschke RA; Curry SC; Warkentin TE; Gerkin RD
    Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia.
    Eekels JJM; Althaus K; Bakchoul T; Kroll H; Kiefel V; Nazy I; Lee LS; Sachs U; Warkentin TE; Greinacher A
    J Thromb Haemost; 2019 Mar; 17(3):525-531. PubMed ID: 30640980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance.
    Rollin J; Charuel N; Gruel Y; Billy S; Guéry EA; May MA; Pouplard C; Vayne C
    J Thromb Haemost; 2022 Nov; 20(11):2646-2655. PubMed ID: 35971886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia.
    Althaus K; Hron G; Strobel U; Abbate R; Rogolino A; Davidson S; Greinacher A; Bakchoul T
    Thromb Res; 2013 Mar; 131(3):e85-90. PubMed ID: 23351665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia.
    Kondo M; Donikian D; Brighton TA
    Methods Mol Biol; 2023; 2663():463-477. PubMed ID: 37204730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.
    Raschke RA; Gallo T; Curry SC; Whiting T; Padilla-Jones A; Warkentin TE; Puri A
    J Thromb Haemost; 2017 Aug; 15(8):1640-1645. PubMed ID: 28622439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients.
    Berry C; Tcherniantchouk O; Ley EJ; Salim A; Mirocha J; Martin-Stone S; Stolpner D; Margulies DR
    J Am Coll Surg; 2011 Jul; 213(1):10-7; discussion 17-8. PubMed ID: 21531584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia.
    Nazy I; Jevtic SD; Moore JC; Huynh A; Smith JW; Kelton JG; Arnold DM
    J Thromb Haemost; 2021 May; 19(5):1342-1347. PubMed ID: 33639037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
    Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
    J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
    Warkentin TE; Pai M; Sheppard JI; Schulman S; Spyropoulos AC; Eikelboom JW
    J Thromb Haemost; 2011 Dec; 9(12):2389-96. PubMed ID: 21883878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.